Review finds links between allergic diseases and mental health conditions
HQ Team November 15, 2024:Allergies are a source of great social and physical impairment for people suffering from them. Treatments are long-drawn, expensive
HQ Team November 15, 2024:Allergies are a source of great social and physical impairment for people suffering from them. Treatments are long-drawn, expensive
HQ Team November 15, 2024: Eli Lilly’s Phase III trial has yielded positive results from the SURMOUNT-1 study of tirzepatide (Zepbound and Mounjaro) for
HQ Team November 14, 2024: Recent research published in Brain Medicine found air pollution as a significant environmental risk factor for Autism Spectrum Disorder
HQ team November 14, 2024: The 29th Conference of the Parties (COP29) to the United Nations Framework Convention on Climate Change (UNFCCC), held
The global diabetic population has risen fourfold to 828 million during the last three decades, with more than a quarter living in India,
HQ Team November 13, 2024: A team of international researchers has developed a non-addictive painkiller that remains inactive until it reaches sites of
HQ Team November 13, 2024: At COP29 in Baku, Azerbaijan, multilateral development banks (MBDs) announced a commitment to $120 billion in climate financing
HQ Team November 13, 2024: ALK-Abelló, the Danish pharma company has acquired exclusive rights to Neffy (epinephrine nasal spray) from ARS Pharmaceuticals for
UN Secretary-General António Guterres outlined a three-point plan to limit global temperature rise to 1.5 degrees Celsius by 2030, including new ways to
Toxic positivity promotes the belief that individuals should maintain happiness regardless of their circumstances. It discourages negative thoughts, even in situations that naturally